Literature DB >> 9442027

Identification of DNA gyrase inhibitor (GyrI) in Escherichia coli.

A Nakanishi1, T Oshida, T Matsushita, S Imajoh-Ohmi, T Ohnuki.   

Abstract

DNA gyrase is an essential enzyme in DNA replication in Escherichia coli. It mediates the introduction of negative supercoils near oriC, removal of positive supercoils ahead of the growing DNA fork, and separation of the two daughter duplexes. In the course of purifying DNA gyrase from E. coli KL16, we found an 18-kDa protein that inhibited the supercoiling activity of DNA gyrase, and we coined it DNA gyrase inhibitory protein (GyrI). Its NH2-terminal amino acid sequence of 16 residues was determined to be identical to that of a putative gene product (a polypeptide of 157 amino acids) encoded by yeeB (EMBL accession no. U00009) and sbmC (Baquero, M. R., Bouzon, M., Varea, J., and Moreno, F. (1995) Mol. Microbiol. 18, 301-311) of E. coli. Assuming the identity of the gene (gyrI) encoding GyrI with the previously reported genes yeeB and sbmC, we cloned the gene after amplification by polymerase chain reaction and purified the 18-kDa protein from an E. coli strain overexpressing it. The purified 18-kDa protein was confirmed to inhibit the supercoiling activity of DNA gyrase in vitro. In vivo, both overexpression and antisense expression of the gyrI gene induced filamentous growth of cells and suppressed cell proliferation. GyrI protein is the first identified chromosomally nucleoid-encoded regulatory factor of DNA gyrase in E. coli.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442027     DOI: 10.1074/jbc.273.4.1933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase.

Authors:  Monalisa Chatterji; Valakunja Nagaraja
Journal:  EMBO Rep       Date:  2002-02-15       Impact factor: 8.807

2.  Plasmid DNA supercoiling and gyrase activity in Escherichia coli wild-type and rpoS stationary-phase cells.

Authors:  Yazmid Reyes-Domínguez; Gabriel Contreras-Ferrat; Jesús Ramírez-Santos; Jorge Membrillo-Hernández; M Carmen Gómez-Eichelmann
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

3.  Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor.

Authors:  Subray S Hegde; Matthew W Vetting; Lesley A Mitchenall; Anthony Maxwell; John S Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

4.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Depletion of RNase HI activity in Escherichia coli lacking DNA topoisomerase I leads to defects in DNA supercoiling and segregation.

Authors:  Valentine Usongo; Flora Nolent; Patrick Sanscartier; Cynthia Tanguay; Sonia Broccoli; Imad Baaklini; Karl Drlica; Marc Drolet
Journal:  Mol Microbiol       Date:  2008-06-28       Impact factor: 3.501

Review 6.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

7.  In vivo titration of mitomycin C action by four Escherichia coli genomic regions on multicopy plasmids.

Authors:  Y Wei; A C Vollmer; R A LaRossa
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 8.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

9.  The SOS Regulatory Network.

Authors:  Lyle A Simmons; James J Foti; Susan E Cohen; Graham C Walker
Journal:  EcoSal Plus       Date:  2008-07-25

10.  DNA Gyrase of Deinococcus radiodurans is characterized as Type II bacterial topoisomerase and its activity is differentially regulated by PprA in vitro.

Authors:  Swathi Kota; Yogendra S Rajpurohit; Vijaya K Charaka; Katsuya Satoh; Issay Narumi; Hari S Misra
Journal:  Extremophiles       Date:  2016-02-05       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.